Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ULY | Urgent.ly | $5.38 | $3.35 | 164.78% | 1.5M | $4.4M | $1.74$17.99 |
| CTMX | CytomX Therapeutics | $7.92 | $3.24 | 69.16% | 78.9M | $793M | $0.40$8.21 |
| AIRS | AirSculpt Technologies | $2.68 | $0.83 | 44.59% | 1.5M | $116M | $1.51$12.00 |
| ACXP | Acurx Pharmaceuticals | $5.27 | $1.39 | 35.83% | 6.2M | $9.9M | $1.33$21.00 |
| NSA | National Storage Affiliates Trust | $40.22 | $9.28 | 29.99% | 10.5M | $2.4B | $27.43$40.95 |
| DSGR | Distribution Solutions Group | $24.75 | $5.44 | 28.17% | 595.5K | $892M | $19.02$33.80 |
| NBIL | GraniteShares ETF Trust - GraniteShares 2x Long Nbis Daily ETF | $16.31 | $3.17 | 24.10% | 2.4M | - | $6.37$38.58 |
| NBIG | Themes ETF Trust - Leverage Shares 2x Long Nbis Daily ETF | $11.52 | $2.24 | 24.09% | 2.2M | - | $4.51$19.45 |
| ARTL | Artelo Biosciences | $4.59 | $0.83 | 22.07% | 34.1K | $2.7M | $3.15$85.80 |
| CING | Cingulate | $10.55 | $1.86 | 21.40% | 1.3M | $67M | $3.20$10.56 |
| LMNX | Tidal Trust II - Defiance Daily Target 2x Long Lmnd ETF | $17.26 | $2.53 | 17.21% | 18.4K | - | $11.68$55.00 |
| LFMD | LifeMD | $4.66 | $0.68 | 17.05% | 1.4M | $191M | $2.56$15.84 |
| CYN | Cyngn | $2.78 | $0.40 | 16.81% | 8.2M | $19M | $1.33$41.54 |
| OPAL | OPAL Fuels | $2.48 | $0.34 | 15.89% | 399K | $62M | $1.26$4.08 |
| AXR | Amrep | $28.22 | $3.79 | 15.51% | 15.9K | $130M | $17.60$28.71 |
| DXST | Decent | $6.61 | $0.89 | 15.46% | 473K | $141M | $1.97$62.00 |
| CLIK | Click | $3.59 | $0.47 | 15.19% | 3.5M | $10M | $3.01$102.90 |
| CVGI | Commercial Vehicle Group | $3.34 | $0.44 | 15.17% | 23.6K | $106M | $0.81$3.42 |
| NUAI | New Era Energy & Digital | $5.78 | $0.76 | 15.14% | 2.4M | $269M | $0.32$9.45 |
| FRSX | Foresight Autonomous | $2.36 | $0.31 | 15.13% | 138.3K | $4.7M | $2.05$15.96 |
| CRCG | Themes ETF Trust - Leverage Shares 2x Long Crcl Daily ETF | $5.02 | $0.64 | 14.61% | 17.4M | - | $0.95$20.92 |
| LVO | LiveOne | $5.86 | $0.75 | 14.58% | 617 | $60M | $3.70$9.80 |
| NRXP | NRx Pharmaceuticals | $2.13 | $0.27 | 14.52% | 1.2M | $59M | $1.58$3.84 |
| GLGG | Themes ETF Trust - Leverage Shares 2x Long Glxy Daily ETF | $7.69 | $0.97 | 14.48% | 23.2K | - | $4.22$45.80 |
| GSIT | Gsi Technology | $9.72 | $1.21 | 14.22% | 816.9K | $308M | $1.62$18.15 |
| IREG | Themes ETF Trust - Leverage Shares 2x Long Iren Daily ETF | $16.93 | $2.06 | 13.89% | 98.8K | - | $11.23$41.60 |
| FWDI | Forward Industries | $5.36 | $0.65 | 13.80% | 45.7K | $392M | $3.51$46.00 |
| GLXG | Galaxy Payroll Group | $2.24 | $0.22 | 10.89% | 1.3K | $12M | $1.54$16.80 |
| HSPTU | Horizon Space Acquisition II Corp. | $7.24 | -$4.37 | -37.64% | 5 | $66M | $7.24$13.50 |
Related Articles
Why I Just Bought These 2 High-Yield REIT Stocks
Keith Speights|Sep 13, 2024
These REIT stocks offer more than just juicy dividend yields.
3 High-Yield Dividend Stocks to Buy Sooner Rather Than Later
Keith Speights|Sep 5, 2024
Now is the time for income investors to buy these great stocks.
Like Life Storage? Consider This Stock First
Liz Brumer|Mar 31, 2023
This often-overlooked stock has outperformed all self-storage REITs for the last five years.
Don't Sleep on This Money-Making Real Estate Stock
Liz Brumer|Jun 28, 2022
Market volatility and fears of recession have put National Storage Affiliates Trust on sale.
1 Small-Cap Stock With 10X Potential
Prosper Junior Bakiny|Oct 27, 2021
This company's coronavirus efforts could pay off big time.
Could This Be the Biggest News in Treating Severe COVID So Far?
Keith Speights|Jul 31, 2021
NRx Pharmaceuticals could have a promising COVID-19 drug on the way.
2 Top Stocks Around $5
Dave Kovaleski|Jan 24, 2021
A low price isn't always a great opportunity, but there's a lot to like in these two companies.
Is This Innovative Cancer Research Biotech a Buy?
Zhiyuan Sun|May 20, 2020
Unlike many other cancer-research companies, CytomX is choosing an unconventional approach: turning tumors' high levels of protein activities against themselves. Will it be successful?
